Influenza virus characterisation, Summary Europe, July 2016
Since week 40/2015, over 139 000 influenza detections across the Region have been reported. Influenza type A viruses have prevailed over type B, with A(H1N1)pdm09 viruses greatly outnumbering A(H3N2) and B/Victoria-lineage detections representing over 91% of the type B viruses assigned to a lineage. Since 1 January 2016, EU/EEA countries have shared 511 influenza-positive specimens with the Francis Crick Institute, London, for detailed characterisation. Since the June report, 28 viruses have been characterised antigenically and genetic analyses are ongoing.
Of the 18 A(H1N1)pdm09 viruses characterised antigenically, all were similar to the vaccine virus A/California/7/2009. Worldwide new genetic subclusters of viruses within the 6B clade have emerged, with two being designated as subclades: 6B.1 defined by HA1 amino acid substitutions S162N and I216T and 6B.2 defined by HA1 amino acid substitutions V152T and V173I. Of the 460 viruses characterised genetically for the 2015–2016 season, 29 (6%) were clade 6B, 426 (92%) were subclade 6B.1 and 11 (2%) were subclade 6B.2.
The two A(H3N2) test viruses characterised by haemagglutination inhibition (HI) assay were poorly recognised by reference antiserum raised against egg-propagated A/Switzerland/9715293/2013, the vaccine virus recommended for use in the 2015–2016 northern hemisphere influenza season. The test viruses were recognised somewhat better by antisera raised against egg-propagated A/Hong Kong/4801/2014, the virus recommended for use in 2016 southern hemisphere and 2016–2017 northern hemisphere influenza vaccines. Of 119 A(H3N2) viruses characterised genetically for the 2015–2016 season: two (2%) were clade 3C.3, 88 (74%) were subclade 3C.2a and 29 (24%) were subclade 3C.3a.
The seven B/Victoria-lineage viruses were antigenically similar to tissue culture-propagated surrogates of B/Brisbane/60/2008. All 161 viruses characterised genetically for the 2015–2016 season fell in genetic clade 1A, as do recently collected viruses worldwide.
One B/Yamagata virus has been characterised since the previous report; it reacted well with post-infection ferret antiserum raised against egg-propagated B/Phuket/3073/2013, the recommended vaccine virus for the northern hemisphere 2015–16 influenza season and for quadrivalent vaccines in the 2016 southern hemisphere and 2016–17 northern hemisphere seasons. Of the 25 viruses characterised genetically for the 2015–2016 season 24 fell in genetic clade 3 and one in clade 2.
Influenza virus characterisation - Summary Europe, November 2021
7 Dec 2021 - This is the second influenza virus characterisation report for the 2021/2022 influenza season. As of week 47/2021, 2 707 influenza detections across the World Health Organization (WHO) European Region were reported to TESSy.
Influenza virus characterisation - Summary Europe, October 2021
16 Nov 2021 - This is the first report for the 2021-2022 influenza season. As of week 44/2021, only 965 influenza detections across the WHO European Region were reported to TESSy.